×
+ All Categories
Log in
English
Français
Español
Deutsch
The top documents tagged [fda slide]
Home >
fda slide
Implementation of a Validated Statistical Computing Environment Presented by Jeff Schumack, Associate Director – Drug Development Information September.
212 views
Challenges in Using a Formal Decision Analysis Approach to Medical Device Approval Larry Kessler, Sc.D. Director, Office of Science and Engineering Laboratories.
216 views
1 Office of Biostatistics Center of Drug Evaluation and Research, FDA Presented at ASA Caucus of Academic Representatives Ram Tiwari, Ph.D. Office of Biostatistics.
223 views
U.S. Regulation of Drug Development and the Role of The Information Professional Alberto Grignolo, Ph.D. Corporate VP and General Manager PAREXEL Consulting.
213 views
1 Biomarkers and Clinical Care Lessons Learned from Case Studies: The Challenges and the Promise of Predictive Biomarkers Steven D. Averbuch, MD Vice President,
220 views
Biomarker Based PGx Strategies Rick Hockett, MD Chief Medical Officer Affymetrix.
219 views
Drug design and testing,. Drug Names Chemical name- describes its molecular structure and distinguishes it from other drugs.
217 views
Seniors.gov and Beyond Mark Pendleton, Senior Librarian for Outreach Services, Thomas Branigan Memorial Library Jim Veatch, Senior Librarian for Technical.
215 views
Changing Scene of Clinical Research Judy Stone, MD © Creative Commons Attribution- Noncommercial-Share Alike.
224 views
Janine Freeman, RD,LD,CDE UGA Extension Nutrition Specialist.
228 views
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events S. Percy Ivy, MD Associate Chief, Senior Investigator Investigational.
215 views
2 3 Mark DuVal, J.D., is president and managing partner of DuVal & Associates. DuVal counsels pharmaceutical, medical device, biotech, food and nutritional.
216 views
< Previous
Next >